Parand Darou Pharma  Parand Darou Pharma

X

Find the latest news about Cyprium Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Cyprium Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
2 Gansevoort Street, 9th Floor New York, NY 10014
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com/news-release/2022/03/21/2406643/28889/en/Fortress-Biotech-Cyprium-Therapeutics-and-Sentynl-Therapeutics-Announce-CUTX-101-Copper-Histidinate-Data-to-be-Presented-at-2022-American-College-of-Medical-Genetics-Annual-Clinica.html

GLOBENEWSWIRE
21 Mar 2022

https://www.globenewswire.com/news-release/2021/12/07/2347337/28889/en/Fortress-Biotech-Cyprium-Therapeutics-and-Sentynl-Therapeutics-Announce-the-Initiation-of-Rolling-Submission-of-a-New-Drug-Application-for-CUTX-101-Copper-Histidinate-for-Treatment.html

GLOBENEWSWIRE
07 Dec 2021

https://www.globenewswire.com/news-release/2021/10/08/2311134/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-Positive-Clinical-Data-for-CUTX-101-Copper-Histidinate-Presented-at-2021-American-Academy-of-Pediatrics-National-Conference-Exhib.html

GLOBENEWSWIRE
08 Oct 2021

https://www.contractpharma.com/contents/view_breaking-news/2021-02-24/cyprium-sentynl-therapeutics-ink-asset-purchase-agreement/?widget=listSection

CONTRACTPHARMA
24 Feb 2021

https://www.globenewswire.com/news-release/2021/02/24/2181393/0/en/Cyprium-Therapeutics-a-Fortress-Biotech-Partner-Company-and-Sentynl-Therapeutics-a-Wholly-owned-Subsidiary-of-the-Zydus-Group-Sign-Development-and-Asset-Purchase-Agreement-for-Cypr.html

GLOBENEWSWIRE
24 Feb 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY